Jason H Lin, MD
Neurology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 2 carriers
- Office
- 1
- Since medical school
- 12 years
- Virginia Commonwealth University, School of Medicine, 2014
Offices
1 location · North East Medical Services · 143 clinicians in this group
Hospitals listed: California Pacific Medical Center- Van Ness Campus · California Pacific Medical Ctr-Davies Campus Hosp. That is not proof they admit you there this week.
Plans that list them
13 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lin’s office at (415) 391-9686 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A155281 · Current
Licensed to practise in California · since 2018 · expires 2027-09-30 · Virginia Commonwealth University, Medical College of Virginia.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Psychiatry and Neurology - Neurology
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
- California Pacific Medical Ctr-Davies Campus HospSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · No emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.187, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for California Pacific Medical Ctr-Davies Campus Hosp
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 1 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.187 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 232 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.56 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 10 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 257 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 721 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.49) · 2,031 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.45) · 2,032 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.35 (0.94 to 5.76) · 419 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 211 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.84 (1.24 to 4.44) · 414 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.95 (2.91 to 20.98) · 218 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.61 (1.47 to 9.75) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 52 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 1.28) · 1,461 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.6 · 58 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.756 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 91 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 65.3 · 84 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -26.6 · 115 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 142 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 55 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 25 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 312 cases | No different | Jan 2024 – Dec 2024 |
What patients said (602 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$3,905
Medicare paid this office $3,905 for 93 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Vitamin d-3 level | 62 | $1,828 | $29 |
| Blood test, thyroid stimulating hormone (tsh) | 41 | $675 | $16 |
| Insertion of needle into vein for collection of blood sample | 79 | $470 | $6 |
Who their Medicare patients are
93 Original Medicare patients in 2024. Average age 75 · Women 58% · Health risk score 1.04. At or below the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 75% · Diabetes 35% · Dementia 22% · Stroke 20% · Depression 18% · Chronic kidney disease 17% · Coronary heart disease 13% · Atrial fibrillation 13%.
The office billed $7,899, Medicare allowed $3,905 and paid $3,905; for 232 services of 15 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 93 | 232 | 75 | 1.04 | $7,899 | $3,905 |
| 2023 | 120 | 223 | 75 | 0.97 | $5,452 | $2,210 |
| 2022 | 112 | 206 | 74 | 1.03 | $4,422 | $1,416 |
| 2021 | 71 | 117 | 74 | 0.82 | $1,898 | $758 |
| 2020 | 53 | 101 | 73 | 1.17 | $8,021 | $2,259 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Insertion of needle into vein for collection of blood sample | 103 | $623 | $6 |
| Blood test, thyroid stimulating hormone (tsh) | 31 | $510 | $16 |
| Vitamin d-3 level | 13 | $377 | $29 |
| Blood test, comprehensive group of blood chemicals | 23 | $248 | $10 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 14 | $89 | $6 |
2022: 4 services
| Blood test, thyroid stimulating hormone (tsh) | 29 | $497 | $17 |
| Insertion of needle into vein for collection of blood sample | 105 | $322 | $3 |
| Blood test, comprehensive group of blood chemicals | 24 | $249 | $10 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 14 | $89 | $6 |
2021: 3 services
| Blood test, thyroid stimulating hormone (tsh) | 20 | $336 | $17 |
| Insertion of needle into vein for collection of blood sample | 68 | $210 | $3 |
| Blood test, comprehensive group of blood chemicals | 11 | $116 | $11 |
2020: 2 services
| Blood test, thyroid stimulating hormone (tsh) | 11 | $184 | $15 |
| Insertion of needle into vein for collection of blood sample | 47 | $158 | $3 |
Medicaid work
$620,705 in 2024
Medicaid paid $620,705 for 10,058 billed services this clinician did in 2024, up to 213 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 3,119 | $605,048 |
| Short return visit (20+ min) | 3,744 | $11,644 |
| Return visit (30+ min) | 868 | $3,724 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion | 85 | $290 |
| Medication list documented in medical record (COA) | 44 | $0 |
| BODY MASS INDEX DOCD | 757 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 574 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 50 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 49 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 768 | $0 |
| 2024 | 10,058 | 10 | 213 | $620,705 |
| 2023 | 9,622 | 10 | 248 | $544,708 |
| 2022 | 6,061 | 10 | 237 | $245,257 |
| 2021 | 4,297 | 4 | 176 | $277,022 |
| 2020 | 4,366 | 6 | 143 | $259,829 |
| 2019 | 257 | 3 | 47 | $13,347 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 3,449 | $535,357 |
| Short return visit (20+ min) | 4,084 | $7,599 |
| Return visit (30+ min) | 838 | $1,751 |
| Medication list documented in medical record (COA) | 72 | $0 |
| BODY MASS INDEX DOCD | 205 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 374 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 43 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 63 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 431 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 63 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 1,530 | $238,700 |
| Return visit (30+ min) | 2,435 | $4,787 |
| Short return visit (20+ min) | 749 | $1,770 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 478 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 85 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 79 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 562 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 86 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 32 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 25 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 1,373 | $273,498 |
| Return visit (30+ min) | 2,600 | $3,524 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 148 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 176 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 1,517 | $256,181 |
| Return visit (30+ min) | 2,393 | $3,464 |
| Short return visit (20+ min) | 281 | $185 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 67 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 14 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 94 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 81 | $13,347 |
| Short return visit (20+ min) | 44 | $0 |
| Return visit (30+ min) | 132 | $0 |
Drugs they prescribed that Part D paid
$293,917
Pharmacies billed $293,917 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (46 of 4,296) in 2024. Above the middle of the specialty; the typical neurology clinician is at 0%.
4,063 generic and fewer than 11 brand-name prescriptions · $293,917 in drug cost · 31 antibiotic prescriptions to 30 people · 83 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Memantine Hcl Er | None | 247 | $30,253 | $122 |
| Eliquis | None | 18 | $28,293 | $1,572 |
| Emgality | Migraine | 36 | $25,470 | $707 |
| Nurtec Odt | None | 21 | $18,984 | $904 |
| Gabapentin | None | 576 | $10,651 | $18 |
See all 59 drugs
| Memantine Hcl Er | None | 247 | $30,253 | $122 |
| Eliquis | None | 18 | $28,293 | $1,572 |
| Emgality | Migraine | 36 | $25,470 | $707 |
| Nurtec Odt | None | 21 | $18,984 | $904 |
| Gabapentin | None | 576 | $10,651 | $18 |
| Memantine | None | 437 | $9,244 | $21 |
| Myrbetriq | None | 16 | $8,717 | $545 |
| Duloxetine | None | 116 | $6,881 | $59 |
| Carbidopa-Levodopa | None | 171 | $6,592 | $39 |
| Donepezil | None | 320 | $4,998 | $16 |
| Carbamazepine Er | None | 20 | $2,459 | $123 |
| Mirtazapine | None | 98 | $2,311 | $24 |
| Levetiracetam | None | 31 | $2,275 | $73 |
| Baclofen | None | 225 | $2,157 | $10 |
| Pregabalin | None | 115 | $1,713 | $15 |
| Rivastigmine | None | 24 | $1,631 | $68 |
| Nortriptyline | None | 69 | $1,378 | $20 |
| Metoprolol | None | 53 | $1,217 | $23 |
| Propranolol | None | 59 | $1,201 | $20 |
| Escitalopram | None | 160 | $1,200 | $7 |
| Entacapone | None | 11 | $1,169 | $106 |
| Lacosamide | None | 11 | $1,168 | $106 |
| Oxcarbazepine | None | 13 | $866 | $67 |
| Bupropion Xl | None | 42 | $841 | $20 |
| Atorvastatin | None | 92 | $748 | $8 |
| Celecoxib | None | 17 | $717 | $42 |
| Trazodone | None | 92 | $648 | $7 |
| Misoprostol | None | 12 | $620 | $52 |
| Meloxicam | None | 77 | $589 | $8 |
| Quetiapine | None | 78 | $534 | $7 |
| Midodrine | None | 22 | $490 | $22 |
| Venlafaxine Hcl Er | None | 26 | $479 | $18 |
| Meclizine | None | 75 | $459 | $6 |
| Bupropion | None | 25 | $455 | $18 |
| Topiramate | None | 16 | $415 | $26 |
| Diclofenac | None | 15 | $286 | $19 |
| Omeprazole | None | 16 | $271 | $17 |
| Pramipexole Dihydrochloride | None | 17 | $264 | $16 |
| Pantoprazole | None | 14 | $261 | $19 |
| Zolpidem | None | 23 | $260 | $11 |
| Lorazepam | None | 41 | $218 | $5 |
| Sertraline | None | 13 | $213 | $16 |
| Triamcinolone Acetonide | None | 45 | $209 | $5 |
| Clopidogrel | None | 14 | $186 | $13 |
| Losartan | None | 11 | $175 | $16 |
| Naproxen | None | 21 | $170 | $8 |
| Clonazepam | None | 53 | $168 | $3 |
| Rizatriptan | None | 14 | $167 | $12 |
| Amlodipine Besylate | None | 28 | $126 | $4 |
| Ibuprofen | None | 17 | $118 | $7 |
| Cyclobenzaprine | None | 20 | $108 | $5 |
| Sumatriptan | None | 11 | $97 | $9 |
| Simvastatin | None | 12 | $95 | $8 |
| Famotidine | None | 20 | $91 | $5 |
| Oxybutynin Chloride | None | 13 | $89 | $7 |
| Hydroxyzine | None | 16 | $70 | $4 |
| Tramadol | None | 37 | $64 | $2 |
| Lamotrigine | None | 12 | $45 | $4 |
| Azithromycin | None | 17 | $31 | $2 |
Year by year
| 2024 | 4,296 | 818 | 1% (46) | None | $293,917 |
| 2023 | 3,477 | 681 | 1% (31) | 4% | $303,463 |
| 2022 | 1,699 | 423 | 1% (13) | None | $119,193 |
| 2021 | 1,717 | 297 | 1% (18) | 6% | $69,584 |
| 2020 | 1,324 | 214 | 1% (15) | 3% | $37,712 |
| 2019 | 101 | 38 | 0% (0) | None | $5,287 |
| 2018 | 134 | 14 | 0% (0) | 10% | $101,998 |
| 2017 | 108 | 12 | 0% (0) | 30% | $108,436 |
| 2016 | 48 | 13 | 0% (0) | None | $16,800 |
| 2015 | 16 | None | 0% (0) | None | $135 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 48 drugs
| Memantine Hcl Er | 192 | $50,912 | $265 |
| Eliquis | 23 | $35,660 | $1,550 |
| Gabapentin | 480 | $14,882 | $31 |
| Donepezil | 241 | $10,433 | $43 |
| Duloxetine | 99 | $10,008 | $101 |
| Memantine | 287 | $9,657 | $34 |
| Baclofen | 193 | $6,248 | $32 |
| Pregabalin | 84 | $5,425 | $65 |
| Carbidopa-Levodopa | 121 | $4,957 | $41 |
| Diclofenac | 133 | $3,144 | $24 |
| Nortriptyline | 71 | $2,932 | $41 |
| Atorvastatin | 95 | $2,610 | $27 |
| Bupropion Xl | 52 | $2,244 | $43 |
| Escitalopram | 98 | $2,156 | $22 |
| Quetiapine | 59 | $1,896 | $32 |
| Mirtazapine | 59 | $1,890 | $32 |
| Metoprolol | 45 | $1,580 | $35 |
| Oxcarbazepine | 12 | $1,502 | $125 |
| Propranolol | 50 | $1,333 | $27 |
| Amantadine | 12 | $1,232 | $103 |
| Propranolol Hcl Er | 16 | $1,142 | $71 |
| Trazodone | 54 | $1,000 | $19 |
| Meclizine | 75 | $968 | $13 |
| Meloxicam | 67 | $947 | $14 |
| Levetiracetam | 15 | $897 | $60 |
| Famotidine | 34 | $894 | $26 |
| Clonazepam | 54 | $657 | $12 |
| Omeprazole | 28 | $653 | $23 |
| Lidocaine-Prilocaine | 14 | $651 | $46 |
| Clopidogrel | 26 | $645 | $25 |
| Topiramate | 15 | $590 | $39 |
| Pantoprazole | 23 | $564 | $25 |
| Prazosin | 13 | $554 | $43 |
| Sertraline | 18 | $553 | $31 |
| Cyclobenzaprine | 34 | $388 | $11 |
| Fluticasone Propionate | 15 | $347 | $23 |
| Venlafaxine Hcl Er | 12 | $325 | $27 |
| Pramipexole Dihydrochloride | 12 | $322 | $27 |
| Tramadol | 23 | $298 | $13 |
| Amlodipine Besylate | 30 | $279 | $9 |
| Naproxen | 18 | $254 | $14 |
| Simvastatin | 11 | $215 | $20 |
| Alendronate | 14 | $208 | $15 |
| Hydroxyzine | 12 | $202 | $17 |
| Losartan | 13 | $163 | $13 |
| Triamcinolone Acetonide | 21 | $138 | $7 |
| Lagevrio (Eua) | 12 | $117 | $10 |
| Lorazepam | 18 | $89 | $5 |
2022: 30 drugs
| Memantine Hcl Er | 81 | $23,164 | $286 |
| Eliquis | 12 | $12,997 | $1,083 |
| Gabapentin | 254 | $6,581 | $26 |
| Baclofen | 140 | $4,860 | $35 |
| Diclofenac | 135 | $4,389 | $33 |
| Memantine | 110 | $2,842 | $26 |
| Duloxetine | 53 | $2,383 | $45 |
| Donepezil | 141 | $2,279 | $16 |
| Pregabalin | 30 | $1,564 | $52 |
| Propranolol Hcl Er | 15 | $1,447 | $96 |
| Lidocaine-Prilocaine | 33 | $1,170 | $35 |
| Nortriptyline | 37 | $1,038 | $28 |
| Carbidopa-Levodopa | 25 | $960 | $38 |
| Propranolol | 29 | $642 | $22 |
| Atorvastatin | 37 | $560 | $15 |
| Escitalopram | 47 | $419 | $9 |
| Cyclobenzaprine | 45 | $394 | $9 |
| Quetiapine | 18 | $385 | $21 |
| Mirtazapine | 19 | $291 | $15 |
| Triamcinolone Acetonide | 14 | $271 | $19 |
| Meclizine | 22 | $173 | $8 |
| Bupropion Xl | 17 | $171 | $10 |
| Trazodone | 16 | $158 | $10 |
| Topiramate | 11 | $135 | $12 |
| Loperamide | 11 | $130 | $12 |
| Pantoprazole | 12 | $110 | $9 |
| Meloxicam | 17 | $60 | $4 |
| Clonazepam | 20 | $59 | $3 |
| Amlodipine Besylate | 11 | $51 | $5 |
| Tramadol | 11 | $34 | $3 |
2021: 29 drugs
| Memantine Hcl Er | 48 | $8,405 | $175 |
| Diclofenac | 176 | $6,693 | $38 |
| Gabapentin | 319 | $4,645 | $15 |
| Lidocaine-Prilocaine | 98 | $3,087 | $31 |
| Baclofen | 106 | $2,338 | $22 |
| Carbidopa-Levodopa Er | 16 | $2,134 | $133 |
| Cyclobenzaprine | 48 | $1,773 | $37 |
| Propranolol Hcl Er | 20 | $1,703 | $85 |
| Donepezil | 170 | $1,482 | $9 |
| Nortriptyline | 56 | $1,289 | $23 |
| Duloxetine | 31 | $1,116 | $36 |
| Pregabalin | 21 | $1,104 | $53 |
| Atorvastatin | 54 | $1,045 | $19 |
| Misoprostol | 15 | $842 | $56 |
| Memantine | 49 | $750 | $15 |
| Carbidopa-Levodopa | 28 | $735 | $26 |
| Escitalopram | 52 | $487 | $9 |
| Propranolol | 21 | $487 | $23 |
| Metoprolol | 17 | $299 | $18 |
| Quetiapine | 15 | $250 | $17 |
| Mirtazapine | 14 | $240 | $17 |
| Clopidogrel | 22 | $226 | $10 |
| Topiramate | 20 | $190 | $10 |
| Meclizine | 20 | $150 | $7 |
| Sertraline | 14 | $111 | $8 |
| Zolpidem | 18 | $105 | $6 |
| Naproxen | 16 | $92 | $6 |
| Tramadol | 16 | $75 | $5 |
| Risperidone | 12 | $46 | $4 |
2020: 23 drugs
| Diclofenac | 195 | $6,434 | $33 |
| Gabapentin | 240 | $3,076 | $13 |
| Memantine Hcl Er | 16 | $2,996 | $187 |
| Nortriptyline | 95 | $1,851 | $19 |
| Baclofen | 74 | $1,682 | $23 |
| Lidocaine-Prilocaine | 44 | $1,679 | $38 |
| Memantine | 47 | $1,660 | $35 |
| Midodrine | 14 | $1,362 | $97 |
| Carbidopa-Levodopa | 35 | $1,308 | $37 |
| Misoprostol | 12 | $970 | $81 |
| Cyclobenzaprine | 39 | $945 | $24 |
| Donepezil | 94 | $785 | $8 |
| Duloxetine | 16 | $439 | $27 |
| Topiramate | 19 | $350 | $18 |
| Atorvastatin | 26 | $262 | $10 |
| Propranolol | 12 | $164 | $14 |
| Risperidone | 14 | $149 | $11 |
| Tizanidine | 24 | $144 | $6 |
| Escitalopram | 12 | $135 | $11 |
| Naproxen | 18 | $111 | $6 |
| Ibuprofen | 13 | $95 | $7 |
| Omeprazole | 11 | $66 | $6 |
| Lorazepam | 15 | $49 | $3 |
2019: 3 drugs
| Gabapentin | 30 | $317 | $11 |
| Nortriptyline | 14 | $183 | $13 |
| Sumatriptan | 11 | $142 | $13 |
2018: 4 drugs
| Glatiramer Acetate | 12 | $61,007 | $5,084 |
| Carbamazepine | 12 | $507 | $42 |
| Baclofen | 15 | $487 | $32 |
| Levetiracetam | 17 | $90 | $5 |
2017: 4 drugs
| Copaxone | 17 | $104,136 | $6,126 |
| Primidone | 11 | $104 | $9 |
| Levetiracetam | 11 | $96 | $9 |
| Nortriptyline | 14 | $70 | $5 |
Money from drug and device companies
$44 in 2025
| 2025 | 1 | 2 | None | $44 |
| 2024 | 1 | 2 | None | $36 |
| 2023 | 1 | 1 | None | $24 |
| 2022 | 2 | 3 | None | $351 |
| 2019 | 2 | 2 | None | $52 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Pfizer | Nurtec Odt | $44 | 2 payments
|
See all 2 published payments
| Pfizer | Meals · 2025-10-28 | Nurtec Odt | $18 |
| Pfizer | Meals · 2025-05-20 | Nurtec Odt | $26 |
See earlier years (2024, 2023, 2022, 2019)
2024: $36
| Pfizer | Nurtec Odt | $36 | 2 payments
|
2023: $24
| Pfizer | Nurtec Odt | $24 | 1 payment
|
2022: $351
| Davol | Phasix Mesh | $319 | 2 payments
|
| Baxter Healthcare | None | $33 | 1 payment
|
2019: $52
| Novartis Pharmaceuticals | Aimovig | $39 | 1 payment
|
| Amgen | Aimovig | $13 | 1 payment
|
Professional record
- NPI
- 1245637784
- Licence
- CA A155281, NY 880229California A155281: Current · expires 2027-09-30
- Trained
- Virginia Commonwealth University, School of Medicine, 2014 · 12 years ago
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Neurology (2084N0400X); Internal medicine (207R00000X)
- Mailing address
- 1520 Stockton St, San Francisco, CA, 94133
- NPI first listed
- 2014-11-26
- NPI last updated
- 2025-07-07
- NPI record certified
- 2025-07-07
This is when the NPI record was last certified, not a medical board exam.